PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
24-Feb-2020 Alkermes' Corporate Presentation to be Webcast at the Cowen and Company 40th Annual Health Care Conference Alkermes plc
24-Feb-2020 Sanofi to create new industry leading European company to provide active pharmaceutical ingredients (API*) Sanofi
24-Feb-2020 Sartorius Introduces BioPAT® Spectro to Enable Raman Spectroscopy Capability and QbD with its ambr® and BIOSTAT STR® Platforms The Sartorius Group
24-Feb-2020 Almirall and Paratek enter into a License Agreement for Seysara® in China Almirall
24-Feb-2020 Positive long-term data in retinal clinical trial ReNeuron Group plc
24-Feb-2020 ASLAN PHARMACEUTICALS TO PRESENT AT 9th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE ASLAN Pharmaceuticals
24-Feb-2020 FDA approves Lundbeck’s Vyepti™ (eptinezumab-jjmr) – the first and only intravenous preventive treatment for migraine H. Lundbeck A/S
24-Feb-2020 Altair Medical awarded FDA Breakthrough Device designation to address the global opioid crisis Altair Medical
24-Feb-2020 Genmab Board of Directors Chairman to Step Down Genmab
24-Feb-2020 Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2019 Results Presentation and Webcast Nordic Nanovector
24-Feb-2020 Kyowa Kirin Announces Approval of CRYSVITA® (burosumab) in Switzerland for the Treatment of Adults and Children with X-Linked Hypophosphatemia (XLH) Kyowa Kirin Co., Ltd
24-Feb-2020 Viking Therapeutics to Participate in Upcoming Investor Conferences Viking Therapeutics, Inc.
24-Feb-2020 Precigen to Announce Fourth Quarter and Full Year 2019 Financial Results on March 2nd Precigen, Inc.
24-Feb-2020 Altair Medical awarded FDA Breakthrough Device designation to address the global opioid crisis Altair Medical
23-Feb-2020 Spherix Announces a Special Dividend Distribution Spherix Incorporated
21-Feb-2020 Kyowa Kirin Announces Approval of CRYSVITA® (burosumab) in Switzerland for the Treatment of Adults and Children with X-Linked Hypophosphatemia (XLH) Kyowa Kirin
21-Feb-2020 Exclusive interview with Pharma Microbiology Boston Conference Chair Lynne Ensor, speaks about Coronavirus SMi Group
21-Feb-2020 Exclusive Interview with Martin Everett, CSO, Antabio, ahead of the Superbugs & Superdrugs Conference SMi Group
21-Feb-2020 Edwards Lifesciences' Every Heartbeat Matters Philanthropic Initiative Expanding To Reach More Patients Edwards Lifesciences Corporation
21-Feb-2020 Thousands of patients to benefit from new way to pick up prescriptions at Boots UK Boots UK